The MammaPrint assay may be able to identify patients with HR+ early breast cancer who could benefit from extended letrozole therapy beyond 5 years, according to researchers.

A meta-analysis of studies showed netupitant-palonosetron more effectively prevented CINV, particularly in the overall and delayed phases, compared with aprepitant.

Researchers sought to analyze deidentified sociodemographic and clinical data for children, adolescents, and young adults in the US who have cancer and COVID-19.

Researchers aimed to identify a standardized practice for the early detection of cutaneous melanoma recurrence.

Interrupting DOAC therapy before surgery can increase the risk for thrombotic events, whereas continuing these medications can increase bleeding risk. Clinicians should adopt a balanced and ...

Nearly half of patients with cancer experience some level of financial hardship (FH), according to a study published in JCO Oncology Practice. Betina Yanez, Ph.

Adding trabectedin to treatment with doxorubicin improved progression-free and overall survival in patients with advanced leiomyosarcoma.

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

Investigators in Japan evaluated 1 week of oral naldemedine for treatment of opioid-induced constipation in cancer patients receiving palliative care in a real-world setting.

HealthDay News — For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation (CF), with ...

A retrospective study explored the impact of preexisting cardiovascular disease on adverse events in patients with hematologic malignancies receiving BTK inhibitors.

A novel CAR T-cell therapy, GCC19CART, has demonstrated activity in patients with heavily pretreated, metastatic colorectal cancer.